The company seeks to dis-cover and develop novel therapeutics and vaccines, with a particular emphasis on antiviral drugs to treat infectious diseases caused by viruses such as hepatitis, influenza, West Nile (WNV), Dengue, and respiratory syncytial (RSV) viruses.SBIR Funding: Phase Zero, Phase Double Zero New Patented Transformer Design Improves Energy Efficiency and Reduces Cost to ManufactureBu